Leap-in to the Future of Cell-Line Development
Presented by Chrysanthi Sitmalidou, Scientist II at Orchard Therapeutics
Panellists
- Metewo Selase Enuameh, Senior Scientist, REGENXIBIO
- Martin Michaelis, Professor of Molecular Medicine, University of Kent
Session Discussion Points
-
Advancements in Cell-Line Development: new technologies and applications
-
Automation Gaps in Cell-Line Development Workflows
-
Next-Generation Cell Line Development: Higher Titres- Shorter Timelines
Register (Free)
Speaker Bio
Chrysanthi is a seasoned scientist with a background in Cell Line Development, Viral Vector Upstream Process Development, and Molecular & Cellular Biology. Holding a Master of Science degree from Brunel University London, she brings over four years of industrial experience to the table. Motivated and dedicated, Chrysanthi is known for her strong work ethic and collaborative spirit, making her a valuable asset in the field of process development.
Addressing the Challenges of Cell and Gene Therapy Translation: From Lab to Patient
- Preclinical R&D
- Clinical Development Pathway
- Patient Access & Advocacy
- Industry/Academic/Healthcare Collaboration